Drug firms' Secret Data Supercharge AI Protein Models

An AI system trained on more than 20,000 protein structures from pharmaceutical companies outperforms AlphaFold-like models that rely only on public data, according to a Nature report by Ewen Callaway published September 14, 2026. The finding indicates that proprietary drug-industry data gives protein-structure prediction models an accuracy edge over public-data-only systems.